Sarah Bernard, our Senior Director BD North America, will be present at the 8th MASH Drug Development Summit.

This event is pivotal for those involved in the development of therapies for Metabolic-Associated Steatohepatitis (MASH), gathering over 120 industry leaders to address challenges and innovations in the field.

📅 Date: 24-26 September

📍 Location: Boston, MA,USA